Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health



Page Path
HOME > Korean J Prev Med > Volume 22(2); 1989 > Article
Original Article Cost-benefit Analysis of Health Screening Test for the Insured.
Seung Hum Yu, Myongsei Sohn, Woo Hyung Cho, Eun Cheol Park, Young Doo Lee, Kyu Sik Lee, Ki Hong Chun
Journal of Preventive Medicine and Public Health 1989;22(2):248-258
  • 37 Download
  • 0 Crossref
  • 0 Scopus
1Department of Preventive Medicine and Public Health, Yonsei University College of Medicine, Korea.
2College of Health Science, Yonsei University, Korea.
3Department of Preventive Medicine, Kosin Medical College, Korea.

As a result of cost-benefit analysis by making a macroscopic approach to the health screening projects conducted 4 times since 1980 for the insured people of the Korea Medical Insurance Corporation, the following conclusions were reached. 1. The direct costs put into the health screening project, and the time costs which were paid by examines or calculated in terms of social costs have been estimated. The results is that the lowest estimation was 10,337 million won and the highest 15,141 million won when a minimum of 1.5 hours of time spent and a maximum 4 hours were applied. 2. In terms of the psychiatric benefits, the lowest estimation was 5,341 million won while the highest was 5,585 million won. 3. In terms of the benefits for each kind of diseases, the lowest estimation of 37,188 million won and highest estimation of 74,383 million won have been calculated for the liver diseases. And for the cardiovascular diseases, the minimum estimation was 14,475 million won while the maximum was 20,532 million won. In case of pulmonary tuberculosis, with external effect benefits being included, the estimation ranged from the minimum of 1,649 million won to the maximum of 1,832 million won. And the estimation of benefits for diabetes mellitus and renal diseases ranged from 89 million won to 92 million won and from 4,567 million won respectively. 4. In comparing costs and benefits, as a results of comparing each highest and lowest estimation, a range of minimum 46,708 million won and maximum 98,071 million won of benefits has been gained.

Related articles

JPMPH : Journal of Preventive Medicine and Public Health